Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms

Area of Science:

• Biotechnology and Nanomedicine
• Drug Delivery Systems

Background:

• Solid lipid nanoparticles (SLNs) emerged in the 1990s as versatile carriers for pharmaceutical and cosmetic applications.
• SLNs are increasingly recognized for their potential as effective carriers in gene delivery systems.
• Despite advances, a deeper understanding of SLN-mediated gene delivery mechanisms is crucial for enhancing therapeutic outcomes.

Purpose of the Study:

• To review recent progress in utilizing SLNs for delivering nucleic acids as therapeutic agents.
• To discuss current technologies for convenient SLN production.
• To elucidate the molecular mechanisms of SLN-nucleic acid complex formation and intracellular cargo release.

Main Methods:

• Review of recent scientific literature on SLN-based gene delivery.
• Analysis of molecular mechanisms governing SLN-nucleic acid interactions.
• Comparison with analogous systems (cationic lipids and polymers) to understand structure-function relationships.

Main Results:

• SLNs offer a viable platform for nucleic acid delivery, with ongoing research into optimizing their efficiency.
• Understanding the assembly and intracellular release mechanisms is key to improving SLN-based gene therapies.
• Analogous studies provide insights into structure-function relationships relevant to SLN gene delivery.

Conclusions:

• Further research into SLN-nucleic acid complexation and release mechanisms is essential.
• Exploring alternative SLNplex assembly methods can lead to sustained nucleic acid release.
• Optimizing SLN-based systems holds significant potential for advancing gene therapy.